+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

The Epigenome and Developmental Origins of Health and Disease

  • Book

  • October 2015
  • Elsevier Science and Technology
  • ID: 3329051

Winner of 2016 BMA Medical Award for Basic and Clinical Sciences

The Epigenome and Developmental Origins of Health and Disease synthesizes the existing knowledge on how the in utero environment could be the most important environment in shaping later risk for various diseases or to conversely promote the health of the offspring.

The book mines the existing literature from a variety of disciplines from toxicology to nutrition to epigenetics to reveal how contrasting maternal in utero environmental changes might be leading to epigenetic convergence and the resulting deleterious phenotypic and physiological effects in our offspring.

It is increasingly becoming apparent that even subtle changes in the mother's diet, stress, and exposure to low concentrations of toxic chemicals at levels deemed safe by the EPA and FDA, such as endocrine disrupting compounds (EDC), can dramatically impact the health of our children, possibly leading to metabolic, cardiovascular, immunological, neurobehavioral disorders, and increased risk for cancer to list but a few examples.

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. The Developmental Origins of Health and Disease (DOHaD) concept: past, present and future.
2. Historical Perspective of Developmental Origins of Health and Disease in Humans
3. DOHaD and the Periconceptional Period, a Critical Window in Time
4. Introduction to Epigenetic Mechanisms: The Probable Common Thread for Various Developmental Origins of Health and Diseases Effects
5. Fetal Neuro-Hormonal Programming and Endocrine Disruption
6. Parental nutrition and developmental origins of health and disease
7. Maternal prenatal stress and the developmental origins of mental health: the role of epigenetics
8. Epigenetics in the Developmental Origin of Cardiovascular Disorders
9. Developmental Effects of Endocrine-Disrupting Chemicals in the Ovary and on Female Fertility
10. Developmental and Epigenetic Origins of Male Reproductive Pathologies
11. Developmental Origins of Childhood Asthma and Allergic Conditions is there evidence of epigenetic regulation?
12. Immune Disorders, Epigenetics, and the Developmental Origins of Health and Disease
13. Neurobehavioral Disorders and DOHaD
14. Metabolic Disorders and DOHaD
15. The developmental origins of renal dysfunction
16. Cancer and DOHaD- Epigenetic reprogramming as a mediator
17. Epigenetic regulation of gastrointestinal epithelial barrier and developmental origin of health and disease
18. How the Father might Epigenetically Program the Risk for Developmental Origins of Health and Disease Effects in his Offspring
19. Linkage Between in Utero Environmental Changes and Preterm Birth
20. Sexual Dimorphism and DOHaD Through the Lens of Epigenetics
21. Transgenerational Epigenetic Inheritance: Past Exposures, Future Diseases
22. The Placenta and DOHaD
23. The Moral and Legal Relevance of DOHaD Effects for Pregnant Mothers
24. Introduction to Moms in Motion (MIM) Chapter
25. Reversing Harmful DOHaD Effects
26. Informational Resources for Developmental Origins of Health and Disease Research

Authors

Cheryl S. Rosenfeld Professor, Department of Biomedical Sciences, University of Missouri, Columbia, MO, United States. Cheryl S. Rosenfeld, DVM, PhD, has published extensively on how maternal diet and developmental exposure to endocrine-disrupting compounds affect offspring outcomes. She has written several review articles and book chapters, including the most recent one on animal models of transgenerational epigenetic effects in Transgenerational Epigenetics: Evidence and Debate, published by Elsevier. She also edited and coauthored the book The Epigenome and Developmental Origins of Health and Disease, which won the BMA Medical Award for Basic and Clinical Sciences in 2016.